RXI Pharma (RXII) – PRNewswire
-
Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update
-
Phio Pharmaceuticals To Present New Data on PD-1 Targeting INTASYL at the 2021 American Association for Cancer Research (AACR) Annual Meeting
-
Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies
-
Phio Pharmaceuticals Announces $7.7 Million Registered Direct Offering of Common Stock Priced At-the-Market
-
Phio Pharmaceuticals Announces Closing of $14.0 Million Private Placement Priced At-the-Market
-
Phio Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
Back to RXII Stock Lookup
